亨廷顿病中的多巴胺拮抗剂:来自安慰剂对照试验 PROOF-HD 的证据

Antidopaminergic Medications and Clinical Outcomes in Huntington Disease: Insights From the PROOF-HD Placebo-Controlled Trial

This review synthesizes evidence from the PROOF-HD placebo arm and related studies, demonstrating that antidopaminergic medication use in Huntington disease correlates with accelerated decline in functional, motor, and cognitive outcomes, emphasizing the need for careful consideration in clinical trials and management.